Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcriptome | 3 | 2024 | 199 | 0.570 |
Why?
|
| Cognitive Dysfunction | 3 | 2023 | 259 | 0.500 |
Why?
|
| Cerebrovascular Circulation | 5 | 2023 | 211 | 0.440 |
Why?
|
| Glioblastoma | 2 | 2022 | 95 | 0.340 |
Why?
|
| Aging | 5 | 2024 | 944 | 0.330 |
Why?
|
| Brain Neoplasms | 2 | 2022 | 288 | 0.290 |
Why?
|
| Resilience, Psychological | 1 | 2024 | 18 | 0.230 |
Why?
|
| Hyperhomocysteinemia | 1 | 2023 | 28 | 0.220 |
Why?
|
| Animals | 12 | 2024 | 9958 | 0.220 |
Why?
|
| Brain | 6 | 2024 | 698 | 0.210 |
Why?
|
| Dementia, Vascular | 1 | 2023 | 51 | 0.200 |
Why?
|
| Mice | 8 | 2024 | 4406 | 0.200 |
Why?
|
| Exoribonucleases | 1 | 2022 | 20 | 0.200 |
Why?
|
| Parabiosis | 1 | 2022 | 17 | 0.200 |
Why?
|
| Neuroprotective Agents | 1 | 2022 | 51 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2021 | 801 | 0.200 |
Why?
|
| Neuroblastoma | 1 | 2022 | 56 | 0.190 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 210 | 0.190 |
Why?
|
| Cognition | 1 | 2024 | 294 | 0.190 |
Why?
|
| White Matter | 1 | 2022 | 89 | 0.180 |
Why?
|
| Brain Stem Neoplasms | 1 | 2020 | 12 | 0.180 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2020 | 22 | 0.180 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 82 | 0.180 |
Why?
|
| Sirolimus | 1 | 2021 | 68 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 322 | 0.180 |
Why?
|
| Benzenesulfonates | 1 | 2019 | 18 | 0.170 |
Why?
|
| Imines | 1 | 2019 | 21 | 0.170 |
Why?
|
| Motor Neurons | 1 | 2020 | 41 | 0.170 |
Why?
|
| Brain Diseases | 1 | 2019 | 35 | 0.170 |
Why?
|
| Glioma | 1 | 2020 | 118 | 0.160 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 77 | 0.160 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 251 | 0.160 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 110 | 0.160 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 133 | 0.160 |
Why?
|
| Neurovascular Coupling | 1 | 2020 | 152 | 0.150 |
Why?
|
| Hippocampus | 1 | 2019 | 186 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 316 | 0.150 |
Why?
|
| Spinal Cord | 1 | 2020 | 202 | 0.150 |
Why?
|
| Naphthalimides | 1 | 2016 | 1 | 0.140 |
Why?
|
| Organophosphonates | 1 | 2016 | 7 | 0.140 |
Why?
|
| Herpesvirus 3, Human | 1 | 2016 | 12 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 3 | 2022 | 1476 | 0.100 |
Why?
|
| Cellular Senescence | 2 | 2024 | 121 | 0.100 |
Why?
|
| Nitrogen Oxides | 2 | 2022 | 40 | 0.100 |
Why?
|
| Humans | 8 | 2024 | 26827 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2022 | 767 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2023 | 1393 | 0.070 |
Why?
|
| Methionine | 1 | 2023 | 37 | 0.060 |
Why?
|
| Diet, High-Fat | 1 | 2024 | 130 | 0.050 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2024 | 119 | 0.050 |
Why?
|
| Neoplastic Processes | 1 | 2022 | 4 | 0.050 |
Why?
|
| Reperfusion | 1 | 2022 | 7 | 0.050 |
Why?
|
| Uracil | 1 | 2022 | 10 | 0.050 |
Why?
|
| Paclitaxel | 1 | 2023 | 183 | 0.050 |
Why?
|
| Muscle, Smooth | 1 | 2022 | 40 | 0.050 |
Why?
|
| Gray Matter | 1 | 2022 | 23 | 0.050 |
Why?
|
| Superoxides | 1 | 2022 | 61 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 439 | 0.050 |
Why?
|
| Age Factors | 1 | 2024 | 716 | 0.050 |
Why?
|
| Diet | 1 | 2023 | 223 | 0.050 |
Why?
|
| Ischemia | 1 | 2022 | 83 | 0.050 |
Why?
|
| Neurosciences | 1 | 2020 | 8 | 0.050 |
Why?
|
| Biomarkers | 1 | 2024 | 733 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2024 | 627 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2023 | 290 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2023 | 324 | 0.040 |
Why?
|
| Cell Movement | 1 | 2022 | 353 | 0.040 |
Why?
|
| Models, Animal | 1 | 2020 | 129 | 0.040 |
Why?
|
| Microcirculation | 1 | 2020 | 111 | 0.040 |
Why?
|
| Antioxidants | 1 | 2022 | 220 | 0.040 |
Why?
|
| Time Factors | 1 | 2024 | 1563 | 0.040 |
Why?
|
| Chickens | 1 | 2019 | 59 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2022 | 646 | 0.040 |
Why?
|
| Inositol | 1 | 2019 | 6 | 0.040 |
Why?
|
| Perfusion Imaging | 1 | 2019 | 5 | 0.040 |
Why?
|
| Choline | 1 | 2019 | 19 | 0.040 |
Why?
|
| Receptors, Notch | 1 | 2019 | 43 | 0.040 |
Why?
|
| Creatine | 1 | 2019 | 32 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2019 | 108 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 2019 | 52 | 0.040 |
Why?
|
| Oxygen | 1 | 2020 | 217 | 0.040 |
Why?
|
| Astrocytes | 1 | 2020 | 73 | 0.040 |
Why?
|
| Microvessels | 1 | 2019 | 85 | 0.040 |
Why?
|
| Contrast Media | 1 | 2019 | 93 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2019 | 159 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 152 | 0.040 |
Why?
|
| Obesity | 1 | 2024 | 650 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 545 | 0.040 |
Why?
|
| Rats | 1 | 2021 | 1545 | 0.040 |
Why?
|
| Oklahoma | 1 | 2020 | 973 | 0.040 |
Why?
|
| Cytostatic Agents | 1 | 2016 | 2 | 0.040 |
Why?
|
| Adenine | 1 | 2016 | 15 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2016 | 34 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2016 | 206 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2016 | 104 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 239 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 1263 | 0.030 |
Why?
|
| Cell Line | 1 | 2016 | 672 | 0.030 |
Why?
|
| Child | 1 | 2020 | 2146 | 0.030 |
Why?
|
| Aged | 1 | 2023 | 5158 | 0.030 |
Why?
|